retatrutide ly3437943 phase 2 trial obesity nejm 2023 Want to learn more about the GLP-3 called retatrutide? Not yet FDA approved but soon. A weight loss game changer The trial that put “24%”

More scientific evidence is needed to confirm long-term effectiveness and safety

Tirzepatide has demonstrated consistent and clinically meaningful weight reduction across multiple studies, establishing it as one of the most promising non-surgical pharmacologic options for obesity management (15, 25)

We are your partner in this process, committed to helping you integrate these powerful tools into a healthier lifestyle

If approved, Retatrutide dosage would be good for long-term body weight management when used with lifestyle support

J Biol Chem 273(32):2041720424 Hartz CS, Nieman KM, Jacobs RL, Vance DE, Schalinske KL (2006) Hepatic phosphatidylethanolamine N-methyltransferase expression is increased in diabetic rats